OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	132
Editorial Board	75
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	56
Rehabilitation interventions in osteoarthritis	56
Update of imaging in the assessment of axial spondyloarthritis	52
Change of the microvascularization in systemic sclerosis, a matter of air	40
Employment outcomes in systemic sclerosis	39
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	39
Environmental factors and rheumatic diseases	38
The inequity of global healthcare in pediatric rheumatology	34
Rheumatic manifestations of HIV/AIDS	31
Pathophysiology and immunolgical basis of axial spondyloarthritis	29
Epidemiology of rheumatic diseases in tropical populations	29
The epidemiology of psoriatic arthritis: A literature review	26
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	25
Index for PART A	24
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	24
The microbiome and systemic sclerosis: A review of current evidence	22
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	21
Genetics of rheumatoid arthritis	20
The role of calcium crystals and their effect on osteoarthritis pathogenesis	20
Osteoporosis in 2022: Care gaps to screening and personalised medicine	19
Genetics of osteoarthritis	19
Editorial Board	18

Index	18
Imaging of crystal-induced arthropathies in 2025	18
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	18
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	18
Editorial Board	18
Patient-reported outcomes in vasculitis	17
Where is bone science taking us?	17
Novel therapies and innovation for systemic sclerosis skin ulceration	17
Editorial Board	16
Diagnostic delay in axial spondylarthritis: A lost battle?	16
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	16
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	16
Systemic lupus erythematosus	16
The burden of osteoarthritis: Is it a rising problem?	16
Preclinical RA: How to halt its progression	16
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	15
Role of diet in hyperuricemia and gout	15
New and future therapies: Changes in the therapeutic armamentarium for SLE	15
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	15
Infection associated Vasculitides	15
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	15
Pregnancy & neonatal outcomes in spondyloarthritis	15
Problems with “Problems with opioids beyond misuse”	14
Calcium pyrophosphate deposition (CPPD) disease – Treatment options	14
Editorial Board	14
Clinical and molecular significance of genetic loci associated with psoriatic arthritis	14
Psoriatic Arthritis: Current status	13
Pregnancy in systemic lupus erythematosus	13
Fecal incontinence and scleroderma: Pathogenesis and unmet needs	12
Exercise in myositis: What is important, the prescription or the person?	12
Risk for osteoporosis and fracture with glucocorticoids	12
Pharmacogenetics of therapies in rheumatoid arthritis: An update	11
Best practice and research advances in many aspects of rheumatology	11
Granzyme K+ CD8 T cells in autoimmunity	11
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	11
Innovations in systemic sclerosis	11
Index	11
Editorial Board	11
Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points	10
Regenerative methods in osteoarthritis	10
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	10
What the rheumatologist needs to know about skin biopsy	10
Unmet needs in psoriatic arthritis	10
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	10
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	9
Pain in osteoarthritis from a symptom to a disease	9
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	9
Treatment of rheumatic adverse events of cancer immunotherapy	9
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis	9
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	9

Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	9
When are patients with osteoarthritis referred for surgery?	9
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	9
Synovial fluid analysis: Relevance for daily clinical practice	9
Impact of sex and gender on axSpA diagnosis and outcomes	8
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	8
Pathogenesis of calcium pyrophosphate deposition disease	8
Editorial Board	8
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	8
Interferonopathies: From concept to clinical practice	8
Index	8
Recent targets of osteoarthritis research	8
Muscle imaging in myositis: MRI, US, and PET	8
Pain syndromes	7
Femoroacetabular impingement – What the rheumatologist needs to know	7
Current treatments and recommendations for Psoriatic Arthritis	7
CARD9 in the pathogenesis of axial spondyloarthritis	7
TNFR2 signalling in inflammatory diseases	7
Insights into the genetic landscape of systemic sclerosis	7
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	7
Preface: Pediatric rheumatology	6
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	6
Pain mechanisms for the practicing rheumatologist	6
Novel therapies in axial spondyloarthritis	6
Pathogenesis of psoriatic arthritis	6
Tropical pyomyositis	5
Imaging in sarcoid disease	5
Myofascial pain – A major player in musculoskeletal pain	5
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	5
Pre-RA: Can early diagnosis lead to prevention?	5
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	5
Editorial Board	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)	5
The global burden of fragility fractures – what are the differences, and where are the gaps	5
Interstitial lung disease imaging for autoimmune diseases	5
Cardiovascular risk in vasculitis	5
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	5
Musculoskeletal manifestations in leprosy	4
Cancer and myositis: Who, when, and how to screen	4
Genetics of vasculitis	4
How to treat monogenic SLE?	4
Non-coding DNA variants for risk in lupus	4
Best practice in rheumatology new developments in ultrasound and MRI imaging of pediatric rheumatic diseases	4
Challenges in the diagnosis of axial spondyloarthritis	4
Treatment overview of axial spondyloarthritis in 2023	3
Highlights of advancement in Rheumatoid Arthritis research and clinical practice	3
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	3
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon	3
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	3
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	3
Cervicogenic headache – How to recognize and treat	3
What is new in pharmacological treatment for osteoarthritis?	3
Systemic lupus erythematosus and damage: What has changed over the past 20 years?	3
Practical approaches for clinicians in chronic pain management: Strategies and solutions	3
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	3
Deficiency of adenosine deaminase 2 (DADA2): Review	3
“Inflammatory or non-inflammatory pain in inflammatory arthritis – How to differentiate it?”	3
Vascular ultrasound in rheumatology practice	3